Companies · Other Health Care

Pinpoint Testing, LLC

LITTLE ROCK · Other Health Care

Diligence memoA one-page analyst read on Pinpoint Testing, LLC — recommendation, valuation, rhythm, risks.
$3.1M
Total raised · real
2
Rounds
0.5×
Latest step-up
Top 46%
Sector rank · raised
Seed
Latest stage · inferred · Thu Jan 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Pinpoint Testing, LLC looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.30× the median modeled value of Seed Other Health Care companies in 2016–2018 (222 peers) — value vs value, same stage and era.
  • Within the normal band (130% of peer median) for its niche.
Dormant
  • Last raise 9.5 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Pinpoint Testing, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
11.0 yr record
Peak capital year was 2017 with $4.7M across 3 filings.
Market position
ahead of 55% of Other Health Care peers
Capital scale is ahead of 55% of Other Health Care peers; modeled value is above 69% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2017: $4.7M across 3 filings.
  • Largest single filing was $2.3M on 2017-01-12.
  • Filing rows sum to $5.4M, while canonical raised total is $3.1M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Pinpoint Testing, LLC is one of 5376 Other Health Care companies tracked from LITTLE ROCK. By capital raised it ranks mid-pack (ahead of 55% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
2013
Year incorporated
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$25M$50M$75M$100MPre-Seed · 2015-07-01 Raised $750K (real) Modeled valuation $23M (est)$750K$23MPre-Seed2015Seed · 2017-01-12 Raised $1.2M (real) Modeled valuation $29M (est)$1.2M$29MSeed2017Seed · 2017-01-12 Raised $2.3M (real) Modeled valuation $58M (est)$2.3M$58MSeed2017Seed · 2017-07-01 Raised $1.2M (real) Modeled valuation $29M (est)$1.2M$29MSeed2017+$1.2M+$2.3M+$1.2MCumulative $5.4M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$750K · 2015
Seed$1.2M · 2017
Seed extension$2.3M · 2017
Seed extension$1.2M · 2017

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$57.7M
Base estimate est.
$2.0M
Conservative case
$452.7M
Upside case
$11.6M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $23.1M · 2015-07-012015Seed · modeled $29.2M · 2017-01-12Seed · modeled $57.7M · 2017-01-12Seed · modeled $29.2M · 2017-07-012017
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
38%
Survival probability
17% low · 58% high
1.54×/yr
Annual markup
2.01×/yr upside case
6.0 yr
Elapsed time used
9.5 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
8 mo
Avg between rounds
$1.5M/yr
Capital velocity
11.0 yr
On record since
2015
First round
4
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 1.3× above median
This company$3.1M
Sector median$2.4M
Latest round — vs other Seed rounds in sector (real $, this stage) 0.7× of median
This company$1.2M
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages) 2.6× above median
This company$57.7M
Sector median$22.1M

Raised more than 55% of sector peers (real $). Modeled value above 69% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #80 of 222.

This companyCohort peer
$10.0M$100.0M$1.0B$1.0M$10.0MCapital raised (log)Eye Academy of America Ltd. · Seed Raised $4.0M · modeled $99.1M (est)Guest House Holdings, LLC · Seed Raised $4.0M · modeled $99.1M (est)Cb Therapeutics Inc. · Seed Raised $4.0M · modeled $99.1M (est)Ruddco Inc. · Seed Raised $4.0M · modeled $99.1M (est)Shift Sciences, LLC · Seed Raised $4.0M · modeled $98.6M (est)BHCP OK4 HH/H Investors, LLC · Seed Raised $4.0M · modeled $97.9M (est)ReNovo, Inc. · Seed Raised $4.0M · modeled $97.9M (est)CCRC of Lenexa, LLC · Seed Raised $3.9M · modeled $97.6M (est)Nocira, Llc · Seed Raised $3.9M · modeled $96.7M (est)PureFlowCath, LLC · Seed Raised $3.8M · modeled $94.6M (est)Prevent Biometrics, Inc. · Seed Raised $4.2M · modeled $94.2M (est)Medal, Inc. · Seed Raised $3.8M · modeled $93.6M (est)Pinpoint Testing, LLC (this company) Raised $3.1M · modeled $57.7M (est)Pinpoint Testing, LLC
CompanyStageRaised · realValue · estvs peer med.
Eye Academy of America Ltd.Seed$4.0M$99.1M2.23×
Guest House Holdings, LLCSeed$4.0M$99.1M2.23×
Cb Therapeutics Inc.Seed$4.0M$99.1M2.23×
Ruddco Inc.Seed$4.0M$99.1M2.23×
Shift Sciences, LLCSeed$4.0M$98.6M2.22×
BHCP OK4 HH/H Investors, LLCSeed$4.0M$97.9M2.21×
ReNovo, Inc.Seed$4.0M$97.9M2.21×
CCRC of Lenexa, LLCSeed$3.9M$97.6M2.20×
Nocira, LlcSeed$3.9M$96.7M2.18×
PureFlowCath, LLCSeed$3.8M$94.6M2.13×
Prevent Biometrics, Inc.Seed$4.2M$94.2M2.12×
Medal, Inc.Seed$3.8M$93.6M2.11×
Pinpoint Testing, LLC this companySeed$3.1M$57.7M1.30×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$750K2015-07-01$4.2M$23.1M85%
Seed$1.2M2017-01-12$5.9M$29.2M90%
Seed$2.3M2017-01-12$11.6M$57.7M90%
Seed$1.2M2017-07-01$5.9M$29.2M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$750K2015-07-01
    • First recorded raise — entered as Pre-Seed.
  2. Seed$1.2M2017-01-12
    • Raised 18 mo later, in step with the ~14 mo sector norm.
    • Round 1.6× larger than the prior — scaling up.
  3. Seed$2.3M2017-01-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.0× larger than the prior — scaling up.
  4. Seed$1.2M2017-07-01
    • Came back fast: 6 mo vs the ~14 mo sector norm.
    • Round 2.0× smaller than the prior — bridge or down round.
Intelligence
2018 ~Q1
Modeled next raise · ~8mo cadence
$1.2M
Modeled next size est.range $1.2M$1.9M
0.5×
Last step-up
$1.5M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Ben Statz2017-01
Charles Kokes2015-07
Cindy Moran2015-07
Gregory Endres2015-07
Jeffrey Moran2015-07
Jim Militello2015-07
Nancy Rusch2015-07
Tom Endres2015-07
Registry & provenance

Pinpoint Testing, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1652109
SEC CIK
2013
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
InPronto, INCOther Health CareSeed$3.1M$62.8Msame sector · same stage
12573849 Canada Inc.Other Health CareSeed$3.1M$61.1Msame sector · same stage
S&K Holdings, Inc.Other Health CareSeed$3.1M$47.0Msame sector · same stage
North River Capstone, LLCOther Health CareSeed$3.0M$60.6Msame sector · same stage
eFamilyCare Inc.Other Health CareSeed$3.1M$62.1Msame sector · same stage
Medipacs, IncOther Health CareSeed$3.0M$50.5Msame sector · same stage
PRP Concepts, Inc.Other Health CareSeed$3.1M$52.4Msame sector · same stage
Opya, Inc.Other Health CareSeed$3.1M$50.8Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Heart Test Laboratories, Inc.Other Health CareSeries A$5.6M86%
Dewpoint Imaging, LLCOther Health CarePre-Seed$270K85%
ARCpoint Inc.Other Health CareSeed$2.6M85%
Parallel Testing Inc.Other Health CarePre-Seed$3.1M84%
Pinscriptive, Inc.Other Health CareSeed$44.1M84%
Usrc Datapoint, LlcOther Health CarePre-Seed$13.9M83%
Echo Testing Group, LLCOther Health CarePre-Seed$18.2M83%
EdgePoint Integrity Solutions, Inc.Other Health CarePre-Seed$4.4M82%
Frequently asked
How much funding has Pinpoint Testing, LLC raised?
Pinpoint Testing, LLC has raised approximately $3.1M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Pinpoint Testing, LLC's estimated valuation?
Provath's modeled valuation for Pinpoint Testing, LLC is approximately $57.7M (modeled range $2.0M–$452.7M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Pinpoint Testing, LLC at?
Pinpoint Testing, LLC's latest modeled financing stage is Seed. Its most recent recorded round closed around Thu Jan 12.
What does Pinpoint Testing, LLC do and where is it based?
Pinpoint Testing, LLC operates in the Other Health Care sector, based in LITTLE ROCK.
Explore related

See where Pinpoint Testing, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Pinpoint Testing, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.